EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?

Olga S Chumakova, Elena A Mershina

Experimental Biology and Medicine · 2024

DOI: 10.3389/ebm.2024.10334 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Olga S Chumakova und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center of Cardiology Named After E. I. Chazov, Moscow, Russia. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Biomarkers, Circulating MicroRNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder associated with an increased risk of arrhythmias, heart failure, and sudden cardiac death. Current imaging and clinical markers are not fully sufficient in accurate diagnosis and patient risk stratification. Although known cardiac biomarkers in blood are used, they lack specificity for HCM and primarily stratify for death due to heart failure in overt cases. Non-coding RNAs, particularly microRNAs, have emerged as promising biomarkers due to their role in regulating gene expression in both healthy and pathological hearts. Circulating microRNA signatures may dynamically reflect the progression of HCM, offering potential utility in diagnosis and disease monitoring as well as inform biologic pathways for innovative therapeutic strategies. However, studying microRNAs in cardiovascular diseases is still in its early stages and poses many challenges. This review focuses on emerging research perspectives using advanced cardiac magnetic resonance techniques. We presume, that the search for circulating miR signatures associated with specific adverse myocardial features observed on cardiac magnetic resonance imaging - such as fibrosis, disarray, and microvascular disease - represents a promising direction in HCM research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicBiomarkersCirculating MicroRNAHumansMagnetic Resonance ImagingMicroRNAsMyocardium

Stichwörter der Autor:innen

biomarkerscardiac magnetic resonancedisarrayfibrosishypertrophic cardiomyopathymicroRNAsmicrovasculaturenon-coding RNAs

Substanzen

BiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • National Medical Research Center of Cardiology Named After E. I. Chazov, Moscow, Russia.
  • Medical Research and Education Center Lomonosov Moscow State University, Moscow, Russia.

Zitieren

APA

Chumakova, O. S., & Mershina, E. A. (2024). Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10334

Vancouver

Chumakova OS, Mershina EA. Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10334

BibTeX
@article{Chumakova2024,
  author = {Chumakova, Olga S and Mershina, Elena A},
  title = {Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?},
  journal = {Experimental Biology and Medicine},
  year = {2024},
  doi = {10.3389/ebm.2024.10334}
}
Kostenlos starten →